Skip to content


Call for papers: Advances in Cancer Immunotherapy

Cancer ImmunotherapyWe are pleased to announce that Journal of Experimental & Clinical Cancer Research has launched a new thematic series on “Advances in Cancer Immunotherapy” to help summarize recent highlights in this field. Click here for further details on the series and for submission information.

Submission deadline: 31st May 2019

Click here to access all thematic series published to date in the Journal of Experimental & Clinical Cancer Research.

Featured Article: Immune checkpoint therapy in liver cancer

New Content ItemPreclinical and clinical studies show immune checkpoint therapy provides survival benefit for greater numbers of patients with liver cancer, including hepatocellular carcinoma and cholangiocarcinoma, two main primary liver cancers. In this review, Feng Xu et al. summarize current knowledge and recent developments in immune checkpoint-based therapies for the treatment of both of these liver cancers and attempt to clarify the mechanisms underlying its effects.

Click here to access the full article.

Click here to access all of the reviews published to date in Journal of Experimental & Clinical Cancer Research.

Aims and scope

Journal of Experimental & Clinical Cancer Research is an online peer-reviewed journal that provides a high-quality forum for all aspects of basic, clinical and translational work in oncology.

Please click here to read more.


Mauro Castelli, Regina Elena National Cancer Institute, Italy

If you would like to contact Journal of Experimental & Clinical Cancer Research, please send an email to:​​​​​​​


Most accessed articles RSS

View all articles

Celebrating the 10th anniversary partnership with BMC

JECCR 10 years​​​​​​​2018 marks the 10th anniversary of the partnership between the Journal of Experimental & Clinical Cancer Research and BMC.

Over the past decade, the journal has established itself among some of the top Oncology titles in Journal Citation Reports. Click here to look back at some of the journal’s milestone achievements and best content from the past 10 years.

2017 Impact Factor

We are delighted to share with our readers that Journal of Experimental & Clinical Cancer Research has an Impact Factor of 6.217 and is currently ranked at 33 out of 222 (Q1) in the Oncology category of Journal Citation Reports (Clarivate Analytics, 2018).

We would like to extend our appreciation to all Editorial Board Members, authors and peer reviewers who have contributed to the journal and enabled this achievement.

Archival content

Journal of Experimental & Clinical Cancer Research has been publishing since 1982.  Prior to publishing with BioMed Central from 2008, Journal of Experimental & Clinical Cancer Research was published in print.  For enquiries about previous content, please contact us on:

Reviewer Acknowledgement

© Syda Productions /

The editorial team of Journal of Experimental & Clinical Cancer Research would like to thank all of our reviewers who have contributed to the journal.

Click here to visit the Reviewer acknowledgements page.


2017 Journal Metrics